How many patents does
Xencor have?
patents
770
families
84
granted
185
applications
585
US
264
EP
94
WO
63
CN
38
JP
30
KR
16
RoW
265
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Xencor
Top ten assignees appearing on patents
2009 - 2018
| xencor | 688 |
| chugai pharmaceutical | 14 |
| allergan | 12 |
| amgen | 6 |
| human genome sciences | 3 |
| ksenkor | 2 |
| xencor inc.xencor | 1 |
2009
| xencor | 45 |
2018
| xencor | 84 |
| amgen | 4 |
| allergan | 2 |
| chugai pharmaceutical | 1 |
Xencor
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| optimized fc variants and methods for their generation | 59 | 2002 |
| fc variants with altered binding to fcrn | 51 | 2004 |
| compositions and methods for treating ige-mediated disorders | 47 | 2008 |
| fc variants with altered binding to fcrn | 34 | 2007 |
| optimized antibodies that target cd19 | 34 | 2006 |
| novel ctla4-ig immunoadhesins | 33 | 2010 |
| fc variants with altered binding to fcrn | 32 | 2004 |
| methods and compositions for inhibiting cd32b expressing cells | 28 | 2007 |
| heterodimeric antibodies that bind cd3 and tumor antigens | 28 | 2014 |
| optimized fc variants and methods for their generation | 26 | 2003 |